219 related articles for article (PubMed ID: 17055343)
1. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma.
Ge H; Zhang JF; Guo BS; He Q; Wang BY; He B; Wang CQ
Vascul Pharmacol; 2007 Feb; 46(2):114-21. PubMed ID: 17055343
[TBL] [Abstract][Full Text] [Related]
2. [Resveratrol inhibits expression of EMMPRIN from macrophages].
Ge H; Zhang JF; Guo BS; He B; Wang BY; Wang CQ
Yao Xue Xue Bao; 2006 Jul; 41(7):625-30. PubMed ID: 17007354
[TBL] [Abstract][Full Text] [Related]
3. Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway.
Fan Y; Meng S; Wang Y; Cao J; Wang C
Int J Mol Med; 2011 Apr; 27(4):607-15. PubMed ID: 21327328
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells.
Huang Z; Wang C; Wei L; Wang J; Fan Y; Wang L; Wang Y; Chen T
Biochem Biophys Res Commun; 2008 Sep; 374(3):517-21. PubMed ID: 18647594
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
Ringseis R; Schulz N; Saal D; Eder K
J Nutr Biochem; 2008 Sep; 19(9):594-603. PubMed ID: 18155510
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cells.
Chuang SY; Yang SH; Chen TY; Pang JH
Eur J Pharmacol; 2011 Nov; 670(2-3):419-26. PubMed ID: 21925496
[TBL] [Abstract][Full Text] [Related]
7. Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells.
Woster AP; Combs CK
J Neurochem; 2007 Oct; 103(1):67-76. PubMed ID: 17573821
[TBL] [Abstract][Full Text] [Related]
8. Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway.
Fan Y; Wang J; Wei L; He B; Wang C; Wang B
Int J Cardiol; 2011 Oct; 152(1):49-55. PubMed ID: 20674992
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells.
Zhang J; Ge H; Wang C; Guo TB; He Q; Shao Q; Fan Y
Int J Cardiol; 2007 May; 117(3):373-80. PubMed ID: 16860414
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of resveratrol-mediated suppression of tissue factor gene expression.
Pendurthi UR; Meng F; Mackman N; Rao LV
Thromb Haemost; 2002 Jan; 87(1):155-62. PubMed ID: 11858183
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
12. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
13. The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages.
Amoruso A; Bardelli C; Fresu LG; Poletti E; Palma A; Federici Canova D; Zeng HW; Ongini E; Brunelleschi S
Pharmacol Res; 2010 Nov; 62(5):391-9. PubMed ID: 20670683
[TBL] [Abstract][Full Text] [Related]
14. Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage.
Billiet L; Furman C; Larigauderie G; Copin C; Page S; Fruchart JC; Brand K; Rouis M
J Cell Physiol; 2008 Jan; 214(1):183-91. PubMed ID: 17579352
[TBL] [Abstract][Full Text] [Related]
15. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins.
Dong W; Wang X; Bi S; Pan Z; Liu S; Yu H; Lu H; Lin X; Wang X; Ma T; Zhang W
Int J Mol Med; 2014 May; 33(5):1161-8. PubMed ID: 24584901
[TBL] [Abstract][Full Text] [Related]
17. PPARγ as a molecular target of EPA anti-inflammatory activity during TNF-α-impaired skeletal muscle cell differentiation.
Magee P; Pearson S; Whittingham-Dowd J; Allen J
J Nutr Biochem; 2012 Nov; 23(11):1440-8. PubMed ID: 22305406
[TBL] [Abstract][Full Text] [Related]
18. Calcium signaling pathway involving calcineurin regulates interleukin-8 gene expression through activation of NF-kappaB in human osteoblast-like cells.
Mitsuyama H; Kambe F; Murakami R; Cao X; Ishiguro N; Seo H
J Bone Miner Res; 2004 Apr; 19(4):671-9. PubMed ID: 15005855
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells.
Li YT; Shen F; Liu BH; Cheng GF
Acta Pharmacol Sin; 2003 Nov; 24(11):1167-71. PubMed ID: 14627504
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
